These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 24374609)
1. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells. Lin J; Wang X; Wu Q; Dai J; Guan H; Cao W; He L; Wang Y Int J Pharm; 2014 Feb; 462(1-2):11-8. PubMed ID: 24374609 [TBL] [Abstract][Full Text] [Related]
2. [Liver targeting of compound liposomes mediated by glycyrrhetinic acid derivative receptor and its effect on hepatic stellate cells]. Wang XL; Guan HD; Qu SX; Xue BW; Li G; Liu XY; Chen LS; Gu H Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5195-5204. PubMed ID: 38114109 [TBL] [Abstract][Full Text] [Related]
3. [Preparation and in vivo study of liposomes mediated by glycyrrhetinic acid derivative ligand 18-GA-Gly]. Jin S; Wang XL; Li G Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4120-4126. PubMed ID: 29271149 [TBL] [Abstract][Full Text] [Related]
4. [Preparation of salvianolic acid B, tanshinone Ⅱ_A, and glycyrrhetinic acid lipid emulsion and its protective effect against acute liver injury induced by acetaminophen]. Zhang XR; Lin T; Wang XL; Wang XJ; Gu H Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4634-4642. PubMed ID: 36164869 [TBL] [Abstract][Full Text] [Related]
5. Behaviour of cell penetrating peptide TAT-modified liposomes loaded with salvianolic acid B on the migration, proliferation, and survival of human skin fibroblasts. Shi J; Guo S; Wu Y; Chen G; Lai J; Xu X J Liposome Res; 2020 Mar; 30(1):93-106. PubMed ID: 31012367 [TBL] [Abstract][Full Text] [Related]
6. A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects. Tian J; Wang L; Wang L; Ke X Drug Deliv; 2014 Nov; 21(7):553-9. PubMed ID: 24215357 [TBL] [Abstract][Full Text] [Related]
7. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid. Guo BH; Cheng Y; Wu W; Lin LP; Lin DH J Liposome Res; 2012 Jun; 22(2):120-7. PubMed ID: 22313057 [TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA - loaded pellets developed for angina chronotherapy: Deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation. Yan HX; Li J; Li ZH; Zhang WL; Liu JP Eur J Pharm Sci; 2015 Aug; 76():156-64. PubMed ID: 25976225 [TBL] [Abstract][Full Text] [Related]
9. In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration. Long W; Zhang SC; Wen L; Mu L; Yang F; Chen G J Ethnopharmacol; 2014 Oct; 156():199-208. PubMed ID: 25218322 [TBL] [Abstract][Full Text] [Related]
10. The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B. Zhang L; Han L; Sun X; Gao D; Qin J; Wang J Fitoterapia; 2012 Jun; 83(4):678-89. PubMed ID: 22391022 [TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Tao YY; Wang QL; Shen L; Fu WW; Liu CH Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304 [TBL] [Abstract][Full Text] [Related]
12. Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma. Xu N; Wu J; Wang W; Sun S; Sun M; Bian Y; Zhang H; Liu S; Yu G Drug Deliv Transl Res; 2024 Sep; 14(9):2386-2402. PubMed ID: 38236508 [TBL] [Abstract][Full Text] [Related]
13. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid. Li J; Xu H; Ke X; Tian J J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855 [TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363 [TBL] [Abstract][Full Text] [Related]
15. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect. Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221 [TBL] [Abstract][Full Text] [Related]
16. [Preparation of tanshinone Ⅱ_A-glycyrrhetinic acid solid lipid nanoparticles and its inhibitory effect on acne]. Chen FN; Wang XL; Xu RR; Wang XJ; Ruan JH Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2449-2456. PubMed ID: 35531692 [TBL] [Abstract][Full Text] [Related]
17. 18α-glycyrrhetinic acid extracted from Glycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell line. Zong L; Qu Y; Xu MY; Dong YW; Lu LG J Dig Dis; 2013 Jun; 14(6):328-36. PubMed ID: 23362936 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination and pharmacokinetic study of water-soluble and lipid-soluble components of danshen in rat plasma using HPLC-UV method. Wang X; Zhang ZR; Fu H; Liu J; Chen Q; Nie Y; Deng L; Gong T Biomed Chromatogr; 2007 Nov; 21(11):1180-5. PubMed ID: 17685392 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of anti-VEGF antibody-modified liposomes loaded with paeonol in the prevention and treatment of hypertrophic scars. Shi J; Wu Y; Guo S; Zhang H; Chen G; Xu X Drug Dev Ind Pharm; 2019 Mar; 45(3):439-455. PubMed ID: 30512972 [TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]